ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis (Q45877985)

17 December 2017

title

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis (English)

1 reference

17 December 2017

1 reference

1 reference

1

1 reference

17 December 2017

author name string

Eunhee Kim

2

1 reference

17 December 2017

Taeyoung Koo

3

1 reference

17 December 2017

Hoguen Kim

4

1 reference

17 December 2017

Young-sook Lee

5

1 reference

17 December 2017

Joo-Hang Kim

6

1 reference

17 December 2017

publication date

1 January 2005

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

61-71

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700769

exact match

0 references

cites work

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Adenovirus immunoregulatory genes and their cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Immune evasion by adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

The E3-11.6K protein of adenovirus is an Asn-glycosylated integral membrane protein that localizes to the nuclear membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

Adenovirus replication-competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700769

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700769

1 reference

17 December 2017

Dimensions Publication ID

1024563460

0 references

1 reference

17 December 2017